Literature DB >> 27401529

Negative symptoms: History of the concept and their position in diagnosis of schizophrenia.

Sonia Dollfus1, John Lyne2.   

Abstract

Current conceptualizations of schizophrenia have been introduced over centuries and continue to progress in recent decades. Symptoms have been divided into several domains, contrasting negative and positive symptoms which are different in their nature, onset, progression and response to treatment. An account of the different historical changes of the concept – essentially nosographic – has led to models attempting to integrate findings for each dimension of the disorder. This paper reviews the history of negative symptoms in diagnosis and how different approaches have been utilised to consider negative symptoms in the concept of schizophrenia. The paper also bridges various international classifications which have evolved and modified the role of negative symptoms in their diagnostic criteria for schizophrenia, which highlights the challenge of defining this disease.

Entities:  

Keywords:  Athymhormia; Deficit syndrome; Hypothymia; Negative symptoms; Nosography; Persistent negative symptoms

Mesh:

Year:  2016        PMID: 27401529     DOI: 10.1016/j.schres.2016.06.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  5 in total

1.  Assessing olfactory, memory, social and circadian phenotypes associated with schizophrenia in a genetic model based on Rim.

Authors:  Sergio Hidalgo; Jorge M Campusano; James J L Hodge
Journal:  Transl Psychiatry       Date:  2021-05-17       Impact factor: 6.222

2.  EPA guidance on treatment of negative symptoms in schizophrenia.

Authors:  S Galderisi; S Kaiser; I Bitter; M Nordentoft; A Mucci; M Sabé; G M Giordano; M Ø Nielsen; L B Glenthøj; P Pezzella; P Falkai; S Dollfus; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-03-17       Impact factor: 5.361

3.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

4.  Enhanced intestinal protein fermentation in schizophrenia.

Authors:  Ying Liang; Xing Shi; Yang Shen; Zhuoran Huang; Jian Wang; Changjun Shao; Yanan Chu; Jing Chen; Jun Yu; Yu Kang
Journal:  BMC Med       Date:  2022-02-09       Impact factor: 8.775

5.  Brain Stimulation and Group Therapy to Improve Gesture and Social Skills in Schizophrenia-The Study Protocol of a Randomized, Sham-Controlled, Three-Arm, Double-Blind Trial.

Authors:  Victoria Chapellier; Anastasia Pavlidou; Daniel R Mueller; Sebastian Walther
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.